Decoding Anti-Müllerian Hormone Trajectories During Menopause: Implications for Cardiovascular Health
Analysis of anti-müllerian hormone (AMH) trajectories reveals two distinct decline patterns across menopause, with slower AMH decline linked to higher postmenopausal cardiovascular risk, independent of premenopausal risk factors.



















